XML 62 R20.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Business Segment Information
9 Months Ended
Jul. 31, 2011
Business Segment Information  
Business Segment Information

Note 14. Business Segment Information

Cooper uses operating income, as presented in our financial reports, as the primary measure of segment profitability. We do not allocate costs from corporate functions to segment operating income. Items below operating income are not considered when measuring the profitability of a segment. We use the same accounting policies to generate segment results as we do for our consolidated results.

Identifiable assets are those used in continuing operations except cash and cash equivalents, which we include as corporate assets. Long-lived assets are property, plant and equipment.

Segment information:

 

Periods Ended July 31,    Three Months     Nine Months  

(In thousands)

   2011     2010     2011     2010  

CooperVision net sales by category:

        

Toric lens

   $ 88,728      $ 76,101      $ 249,397      $ 214,359   

Multifocal lens

     19,677        18,405        54,390        53,373   

Single-use sphere lens

     64,628        53,545        176,498        150,900   

Non single-use sphere and other eye care products and other

     125,219        100,990        336,887        288,643   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total CooperVision net sales

     298,252        249,041        817,172        707,275   

CooperSurgical net sales

     53,144        46,594        152,754        137,890   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total net sales

   $ 351,396      $ 295,635      $ 969,926      $ 845,165   
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating income (loss):

        

CooperVision

   $ 41,528      $ 47,555      $ 148,342      $ 114,689   

CooperSurgical

     13,013        11,851        37,481        33,006   

Headquarters

     (8,654     (8,010     (24,888     (20,287
  

 

 

   

 

 

   

 

 

   

 

 

 

Total operating income

     45,887        51,396        160,935        127,408   

Interest expense

     3,217        8,729        14,436        28,684   

Loss on extinguishment of debt

     0        0        16,487        0   

Litigation settlement charge

     0        0        0        27,000   

Other income (expense), net

     386        985        (128     (1,174
  

 

 

   

 

 

   

 

 

   

 

 

 

Income before income taxes

   $ 43,056      $ 43,652      $ 129,884      $ 70,550   
  

 

 

   

 

 

   

 

 

   

 

 

 

(In thousands)

   July 31, 2011      October 31, 2010  

Identifiable assets:

     

CooperVision

   $ 2,210,251       $ 2,141,685   

CooperSurgical

     336,097         328,931   

Headquarters

     68,986         54,402   
  

 

 

    

 

 

 

Total

   $ 2,615,334       $ 2,525,018   
  

 

 

    

 

 

 

Geographic information:

 

Periods Ended July 31,

(In thousands)

   Three Months      Nine Months  
   2011      2010      2011      2010  

Net sales to external customers by country of domicile:

           

United States

   $ 159,506       $ 145,923       $ 447,711       $ 408,976   

Europe

     110,792         88,206         295,196         256,452   

Rest of world

     81,098         61,506         227,019         179,737   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 351,396       $ 295,635       $ 969,926       $ 845,165   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

(In thousands)

   July 31, 2011      October 31, 2010  

Long-lived assets by country of domicile:

     

United States

   $ 364,062       $ 357,200   

Europe

     227,042         227,780   

Rest of world

     9,990         8,907   
  

 

 

    

 

 

 

Total

   $ 601,094       $ 593,887